Based on the findings, the researchers suggest that semaglutide lowers body weight by directly interacting with diverse GLP-1R populations and directly and indirectly affecting the activity of neural pathways involved in food intake, reward, and energy expenditure
Remember, these alternatives do not have the same pharmaceutical efficacy as prescription medications
The incidence per 1000 patientyears for rMACE5 was 16.7 (95% CI 13.919.8) for the semaglutide cohort and 21.0 (95% CI 17.924.4) for the tirzepatide cohort (Figure 3A)
Why is Fatty Liver Disease on The Rise
Novo Nordisk, the company that makes Wegovy, groups dysesthesia with several related skin or nerve-like sensations, including paresthesia, hyperesthesia, allodynia, skin burning sensation, skin pain, and sensitive skin